Structured Summary
Abstract
A quinazoline derivative and ANTINEOPLASTIC AGENT that functions as a PROTEIN KINASE INHIBITOR for EGFR associated tyrosine kinase. It is used in the treatment of NON-SMALL CELL LUNG CANCER.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
19 entry terms
- Erlotinib HCl
- HCl, Erlotinib
- Hydrochloride, Erlotinib
- 11C-erlotinib
- CP 358,774
- CP 358774
- CP-358,774
- CP-358774
- Erlotinib
- N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine
- OSI-774
- Tarceva
- 11C erlotinib
- 358,774, CP
- 358774, CP
- CP358,774
- CP358774
- OSI 774
- OSI774
MeSH Record
Aspects Covered
25 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analogs & derivatives, analysis, antagonists & inhibitors, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.
MeSH Record
History Note
2016 (1999)
MeSH Hierarchy
Tree Number
AMA Style
References
- National Library of Medicine. Erlotinib Hydrochloride. Medical Subject Headings (MeSH). 2026. Unique ID D000069347. http://id.nlm.nih.gov/mesh/2026/D000069347
- Erlotinib Hydrochloride. In: Wikidata. https://www.wikidata.org/wiki/Q27124083